Matinas BioPharma
MTNB
$0.16
Share price
-5.42%
Change (1 day)
-56.86%
Change (1 year)
Categories
Matinas BioPharma (MTNB) - Total debt
Total debt on the balance sheet as of March 2024 : $3.39 M
According to Matinas BioPharma's latest financial reports the company's total debt is $3.39 M. A company’s total debt is the sum of all current and non-current debts.
Matinas BioPharma - Total debt on balance sheet (from 2013 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $4.12 M | -12.31% |
| 2021-12-31 | $4.7 M | 25.41% |
| 2020-12-31 | $3.75 M | -11.31% |
| 2019-12-31 | $4.22 M | 982.17% |
| 2018-12-31 | $0.39 M | 47.51% |
| 2017-12-31 | $0.26 M | 83.41% |
| 2016-12-31 | $0.14 M | 1182.55% |
| 2015-12-31 | $0.01 M | -81.12% |
| 2014-12-31 | $0.05 M | |
| 2013-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.77 M | -18.36% | 🇺🇸 USA |